Gene expression profiles displayed by peripheral blood mononuclear cells from patients with type 2 diabetes mellitus focusing on biological processes implicated on the pathogenesis of the disease

Gene

Volumn 511, Issue 2, 2012, Pages 151-160

  Manoel Caetano, Fernanda S ^a   Xavier, Danilo J ^a   Evangelista, Adriane F ^a   Takahashi, Paula ^a   Collares, Cristhianna V ^a   Puthier, Denis ^b   Foss Freitas, Maria C ^a   Foss, Milton C ^a   Donadi, Eduardo A ^a   Passos, Geraldo A ^a   Sakamoto Hojo, Elza T ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Aix Marseille university   (France)

Author keywords

DNA repair; Gene expression; Gene set analysis; Inflammatory response; Oxidative stress; Type 2 diabetes mellitus

Indexed keywords

ADIPOCYTOKINE; CERAMIDE; DNA; FATTY ACID; HEMOGLOBIN A1C; RNA;

ADULT; AGE DISTRIBUTION; AGED; APOPTOSIS; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA REPAIR; DOWN REGULATION; FATTY ACID METABOLISM; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOME; GLUCOSE BLOOD LEVEL; HUMAN; HYBRIDIZATION; HYPOXIA; IMMUNITY; INFLAMMATION; INSULIN RESISTANCE; MALE; MENOPAUSE; MICROARRAY ANALYSIS; MOLECULAR MECHANICS; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RNA EXTRACTION; SIGNAL TRANSDUCTION; UPREGULATION;

ADULT; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE STRESS;

EID: 84868208977     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.09.090     Document Type: Article

References (67)

1. Balasubramanyam M., Premanand C., Mohan V. The lymphocyte as a cellular model to study insights into the pathophysiology of diabetes and its complications. Ann. N. Y. Acad. Sci. 2002, 958:399-402.
2. Belkina A.C., Denis G.V. Obesity genes and insulin resistance. Curr. Opin. Endocrinol. Diabetes Obes. 2010, 17:472-477.
3. Bertram M.J., et al. Identification of a gene that reverses the immortal phenotype of a subset of cells and is a member of a novel family of transcription factor-like genes. Mol. Cell. Biol. 1999, 19:1479-1485.
4. Bikman B.T., Summers S.A. Ceramides as modulators of cellular and whole-body metabolism. J. Clin. Invest. 2011, 121:4222-4230.
5. Blasiak J., et al. DNA damage and repair in type 2 diabetes mellitus. Mutat. Res. 2004, 554:297-304.
6. Bloomgarden Z.T. American Diabetes Association Annual Meeting, 1997. Type 2 diabetes. Diabetes Care 1997, 20:1791-1795.
7. Boden G., Shulman G.I. Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β-cell dysfunction. Eur. J. Clin. Invest. 2002, 32(Suppl. 3):14-23.
8. Boeri D., Maiello M., Lorenzi M. Increased prevalence of microthromboses in retinal capillaries of diabetic individuals. Diabetes 2001, 50:1432-1439.
9. Brasacchio D., et al. Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes 2009, 58:1229-1236.
10. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414:813-820.
11. Burke B., et al. Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy. Am. J. Pathol. 2003, 163:1233-1243.
12. Dasu M.R., Devaraj S., Park S., Jialal I. Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects. Diabetes Care 2010, 33:861-868.
13. Donath M.Y., Shoelson S.E. Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 2011, 11:98-107.
14. Eisen M.B., Spellman P.T., Brown P.O., Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:14863-14868.
15. El-Osta A., et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J. Exp. Med. 2008, 205:2409-2417.
16. Gokulakrishnan K., Mohanavalli K.T., Monickaraj F., Mohan V., Balasubramanyam M. Subclinical inflammation/oxidation as revealed by altered gene expression profiles in subjects with impaired glucose tolerance and type 2 diabetes patients. Mol. Cell. Biochem. 2009, 324:173-181.
17. González F., Rote N.S., Minium J., Kirwan J.P. Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2006, 91:336-340.
18. Grayson B.L., Wang L., Aune T.M. Peripheral blood gene expression profiles in metabolic syndrome, coronary artery disease and type 2 diabetes. Genes Immun. 2011, 12:341-351.
19. Gudz T.I., Tserng K.Y., Hoppel C.L. Direct inhibition of mitochondrial respiratory chain complex III by cell-permeable ceramide. J. Biol. Chem. 1997, 272:24154-24158.
20. Henriksen E.J., Diamond-Stanic M.K., Marchionne E.M. Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radic. Biol. Med. 2011, 51:993-999.
21. Hirosumi J., et al. A central role for JNK in obesity and insulin resistance. Nature 2002, 420:333-336.
22. Holland W.L., Summers S.A. Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. Endocr. Rev. 2008, 29:381-402.
23. Hossain P., Kawar B., El Nahas M. Obesity and diabetes in the developing world-a growing challenge. N. Engl. J. Med. 2007, 356:213-215.
24. Howard J.K., Flier J.S. Attenuation of leptin and insulin signaling by SOCS proteins. Trends Endocrinol. Metab. 2006, 17:365-371.
25. Huang N.L., Chiang S.H., Hsueh C.H., Liang Y.J., Chen Y.L., Lai L.P. Metformin inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation. Int. J. Cardiol. 2009, 134:169-175.
26. Hummasti S., Hotamisligil G.S. Endoplasmic reticulum stress and inflammation in obesity and diabetes. Circ. Res. 2010, 107:579-591.
27. Hundal R.S., et al. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J. Clin. Invest. 2002, 109:1321-1326.
28. Kabe Y., Ando K., Hirao S., Yoshida M., Handa H. Redox regulation of NF-kappaB activation: distinct redox regulation between the cytoplasm and the nucleus. Antioxid. Redox Signal 2005, 7:395-403.
29. Kahn S.E., Hull R.L., Utzschneider K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006, 444:840-846.
30. Karin M. How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex. Oncogene 1999, 18:6867-6874.
31. Kirpichnikov D., McFarlane S.I., Sowers J.R. Metformin: an update. Ann. Intern. Med. 2002, 137:25-33.
32. Kolesnick R.N., Kronke M. Regulation of ceramide production and apoptosis. Annu. Rev. Physiol. 1998, 60:643-665.
33. Lebrun P., Van Obberghen E. SOCS proteins causing trouble in insulin action. Acta Physiol. (Oxf) 2008, 192:29-36.
34. Li X., Becker K.A., Zhang Y. Ceramide in redox signaling and cardiovascular diseases. Cell. Physiol. Biochem. 2010, 26:41-48.
35. Liew C.C., Ma J., Tang H.C., Zheng R., Dempsey A.A. The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J Lab Clin Med. 2006, 147:126-132.
36. Marselli L., et al. Gene expression profiles of beta-cell enriched tissue obtained by laser capture microdissection from subjects with type 2 diabetes. PLoS One 2010, 5:e11499.
37. Matsuoka S., et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007, 316:1160-1166.
38. Mercurio F., et al. IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 1997, 278:860-866.
39. Mohan V., Deepa R., Velmurugan K., Premalatha G. Association of C-reactive protein with body fat, diabetes and coronary artery disease in Asian Indians: the Chennai Urban Rural Epidemiology Study (CURES-6). Diabet. Med. 2005, 22:863-870.
40. Nam D., Kim S.Y. Gene-set approach for expression pattern analysis. Brief Bioinform. 2008, 9:189-197.
41. Nikolajczyk B.S., Jagannathan-Bogdan M., Shin H., Gyurko R. State of the union between metabolism and the immune system in type 2 diabetes. Genes Immun. 2011, 12:239-250.
42. Nold M.F., Nold-Petry C.A., Zepp J.A., Palmer B.E., Bufler P., Dinarello C.A. IL-37 is a fundamental inhibitor of innate immunity. Nat. Immunol. 2010, 11:1014-1022.
43. Olefsky J.M., Glass C.K. Macrophages, inflammation, and insulin resistance. Annu. Rev. Physiol. 2010, 72:219-246.
44. Pácal L., et al. Parameters of oxidative stress, DNA damage and DNA repair in type 1 and type 2 diabetes mellitus. Arch. Physiol. Biochem. 2011, 117:222-230.
45. Palsgaard J., et al. Gene expression in skeletal muscle biopsies from people with type 2 diabetes and relatives: differential regulation of insulin signaling pathways. PLoS One 2009, 4:e6575.
46. Pan G., et al. IL-1H, an interleukin 1-related protein that binds IL-18 receptor/IL-1Rrp. Cytokine 2001, 13:1-7.
47. Pan H.Z., Chang D., Feng L.G., Xu F.J., Kuang H.Y., Lu M.J. Oxidative damage to DNA and its relationship with diabetic complications. Biomed. Environ. Sci. 2007, 20:160-163.
48. Pickup J.C., Mattock M.B., Chusney G.D., Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997, 40:1286-1292.
49. Pittas A.G., Joseph N.A., Greenberg A.S. Adipocytokines and insulin resistance. J. Clin. Endocrinol. Metab. 2004, 89:447-452.
50. Rozenova K.A., Deevska G.M., Karakashian A.A., Nikolova-Karakashian M.N. Studies on the role of acid sphingomyelinase and ceramide in the regulation of tumor necrosis factor alpha (TNFalpha)-converting enzyme activity and TNFalpha secretion in macrophages. J. Biol. Chem. 2010, 285:21103-21113.
51. Saltiel A.R. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 2001, 104:517-529.
52. Samuel V.T., Shulman G.I. Mechanisms for insulin resistance: common threads and missing links. Cell 2012, 148:852-871.
53. Sancar A., Lindsey-Boltz L.A., Unsal-Kaçmaz K., Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem. 2004, 73:39-85.
54. Schrauwen P., Hesselink M.K. Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes. Diabetes 2004, 53:1412-1417.
55. Schrauwen P., et al. Uncoupling protein 3 content is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 2011, 50:2870-2873.
56. Segal E., Friedman N., Koller D., Regev A. A module map showing conditional activity of expression modules in cancer. Nat. Genet. 2004, 36:1090-1098.
57. SOURCE Access August 25, 2011. http://source.stanford.edu/.
58. Stelter P., Ulrich H.D. Control of spontaneous and damage-induced mutagenesis by SUMO and ubiquitin conjugation. Nature 2003, 425:188-191.
59. Stumvoll M., Goldstein B.J., van Haeften T.W. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005, 365:1333-1346.
60. Summers S.A. Sphingolipids and insulin resistance: the five Ws. Curr. Opin. Lipidol. 2010, 21:128-135.
61. Summers S.A., Garza L.A., Zhou H., Birnbaum M.J. Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide. Mol. Cell. Biol. 1998, 18:5457-5464.
62. Takamura T., et al. Gene expression profiles in peripheral blood mononuclear cells reflect the pathophysiology of type 2 diabetes. Biochem. Biophys. Res. Commun. 2007, 361:379-384.
63. Tsiotra P.C., et al. Visfatin, TNF-alpha and IL-6 mRNA expression is increased in mononuclear cells from type 2 diabetic women. Horm. Metab. Res. 2007, 39:758-763.
64. World Health Organization (WHO) Access July 22, 2011. http://www.who.int/mediacentre/factsheets/fs312/en/.
65. Wu M.C., Lin X. Prior biological knowledge-based approaches for the analysis of genome-wide expression profiles using gene sets and pathways. Stat. Methods Med. Res. 2009, 18:577-593.
66. Yang Y.L., et al. Gene expression profile of human skeletal muscle and adipose tissue of Chinese Han patients with type 2 diabetes mellitus. Biomed. Environ. Sci. 2009, 22:359-368.
67. Zhang J., Gerhardinger C., Lorenzi M. Early complement activation and decreased levels of glycosylphosphatidylinositol-anchored complement inhibitors in human and experimental diabetic retinopathy. Diabetes 2002, 51:3499-3504.